Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2017-11-16 23:09:02 UTC
Update Date2022-03-07 03:18:13 UTC
HMDB IDHMDB0240218
Secondary Accession NumbersNone
Metabolite Identification
Common NameDexchlorpheniramine
DescriptionDexchlorpheniramine, also known as dapriton or polaramin, belongs to the class of organic compounds known as pheniramines. Pheniramines are compounds containing a pheniramine moiety, which is structurally characterized by the presence of a 2-benzylpyridine linked to an dimethyl(propyl)amine to form a dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine skeleton. In humans, dexchlorpheniramine is involved in the dexchlorpheniramine h1-antihistamine action pathway. Based on a literature review a significant number of articles have been published on Dexchlorpheniramine.
Structure
Data?1563892730
Synonyms
ValueSource
(+)-ChlorpheniramineChEBI
(S)-(+)-2-[p-Chloro-alpha-[2-(dimethylamino)ethyl]benzyl]pyridineChEBI
(S)-gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamineChEBI
D-ChlorpheniramineChEBI
DapritonChEBI
DexchlorpheniraminumChEBI
DexclorfeniraminaChEBI
D-ChloropheniramineKegg
(S)-(+)-2-[p-Chloro-a-[2-(dimethylamino)ethyl]benzyl]pyridineGenerator
(S)-(+)-2-[p-Chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridineGenerator
(S)-g-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamineGenerator
(S)-Γ-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamineGenerator
DexclorHMDB
Dexchlorpheniramine maleate (1:1), (R)-isomerHMDB
Dexchlorpheniramine, (+-)-isomerHMDB
DexclorfeniramineHMDB
PolaraminHMDB
Polargen TDHMDB
Dexchlorpheniramine maleate (1:1), (+-)-isomerHMDB
Dexchlorpheniramine, (R)-isomerHMDB
Dextrochlorpheniramine maleateHMDB
PolaronilHMDB
PolaramineHMDB
Dexchlorpheniramine maleateHMDB
Dexchlorpheniramine maleate (1:1), (S)-isomerHMDB
Dexchlorpheniramine monohydrochlorideHMDB
Dexchlorpheniramine sodium maleate (1:1)HMDB
Dexchlorpheniramine, monohydrochloride, (S)-isomerHMDB
Chemical FormulaC16H19ClN2
Average Molecular Weight274.79
Monoisotopic Molecular Weight274.1236763
IUPAC Name[(3S)-3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine
Traditional Name(+)-chlorpheniramine
CAS Registry Number25523-97-1
SMILES
CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=NC=CC=C1
InChI Identifier
InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1
InChI KeySOYKEARSMXGVTM-HNNXBMFYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as pheniramines. Pheniramines are compounds containing a pheniramine moiety, which is structurally characterized by the presence of a 2-benzylpyridine linked to an dimethyl(propyl)amine to form a dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine skeleton.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassPyridines and derivatives
Sub ClassPheniramines
Direct ParentPheniramines
Alternative Parents
Substituents
  • Pheniramine
  • Chlorobenzene
  • Halobenzene
  • Aralkylamine
  • Aryl chloride
  • Benzenoid
  • Monocyclic benzene moiety
  • Aryl halide
  • Heteroaromatic compound
  • Tertiary aliphatic amine
  • Tertiary amine
  • Azacycle
  • Organic nitrogen compound
  • Organonitrogen compound
  • Organochloride
  • Organohalogen compound
  • Amine
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.74ALOGPS
logP3.58ChemAxon
logS-3.7ALOGPS
pKa (Strongest Basic)9.47ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area16.13 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity80.85 m³·mol⁻¹ChemAxon
Polarizability30.82 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+167.8630932474
DeepCCS[M-H]-165.50230932474
DeepCCS[M-2H]-198.38830932474
DeepCCS[M+Na]+173.95330932474
AllCCS[M+H]+162.032859911
AllCCS[M+H-H2O]+158.332859911
AllCCS[M+NH4]+165.632859911
AllCCS[M+Na]+166.632859911
AllCCS[M-H]-168.132859911
AllCCS[M+Na-2H]-168.232859911
AllCCS[M+HCOO]-168.332859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.5.76 minutes32390414
Predicted by Siyang on May 30, 20229.9383 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.8 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid799.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid233.4 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid138.6 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid176.5 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid90.2 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid313.7 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid323.4 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)535.4 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid733.1 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid52.9 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid921.8 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid182.3 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid273.7 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate462.6 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA201.6 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water17.4 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
DexchlorpheniramineCN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=NC=CC=C12913.1Standard polar33892256
DexchlorpheniramineCN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=NC=CC=C12016.3Standard non polar33892256
DexchlorpheniramineCN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=NC=CC=C12001.4Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Dexchlorpheniramine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4i-9380000000-f4a0f7b13adeafb1762d2017-08-28Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Dexchlorpheniramine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Dexchlorpheniramine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine LC-ESI-qTof , Positive-QTOFsplash10-0uy0-0960000000-24a36e80af50293ed70d2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine , positive-QTOFsplash10-001i-0190000000-f6ef5e736260c9c22a162017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine , positive-QTOFsplash10-0uy0-0960000000-24a36e80af50293ed70d2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine 40V, Negative-QTOFsplash10-0006-9350000000-9779048010f442953f052021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine 20V, Negative-QTOFsplash10-020v-9760000000-7a2dde5051e33fb99e9b2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine 10V, Negative-QTOFsplash10-00di-1290000000-781890d92c473a549bee2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine 35V, Positive-QTOFsplash10-001i-0490000000-bd5f7072acbea14ac94b2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine 20V, Positive-QTOFsplash10-001i-0090000000-7bdad05e8a60c7e72e2a2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine 40V, Positive-QTOFsplash10-014i-0930000000-737ef0ba4ac30a71f3df2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Dexchlorpheniramine 10V, Positive-QTOFsplash10-001i-0090000000-29b571daf91aa7b991432021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 10V, Positive-QTOFsplash10-004i-0090000000-9b4d486e9c2c7712ca4d2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 20V, Positive-QTOFsplash10-0059-0190000000-2c96b165338a445b284d2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 40V, Positive-QTOFsplash10-0ue9-3960000000-73025748bd5a004599382017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 10V, Negative-QTOFsplash10-00di-0090000000-90a6e640c735788d17ca2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 20V, Negative-QTOFsplash10-00di-1090000000-89ac3cf688134ba8a50b2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 40V, Negative-QTOFsplash10-01tc-6490000000-4242ef7cec7b0b0a73932017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 10V, Negative-QTOFsplash10-00di-0090000000-df52e539d08e1efa7d952021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 20V, Negative-QTOFsplash10-00di-4190000000-96b9d2a99d0b210996622021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 40V, Negative-QTOFsplash10-0ue9-7290000000-01c0916a8749a49cbb872021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 10V, Positive-QTOFsplash10-003r-0090000000-5f85b20ee35517cd81922021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 20V, Positive-QTOFsplash10-001i-0090000000-2b9a28bfe8944378684a2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dexchlorpheniramine 40V, Positive-QTOFsplash10-0fsi-1590000000-38bfc333cd948f84c9292021-09-22Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB13679
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID30576
KEGG Compound IDC06946
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkDexchlorpheniramine
METLIN IDNot Available
PubChem Compound33036
PDB IDNot Available
ChEBI ID4464
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Theunissen EL, Vermeeren A, Ramaekers JG: Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br J Clin Pharmacol. 2006 Jan;61(1):79-86. [PubMed:16390354 ]